PNC-27 Price Comparison — Compare 2 Vendors
Price Comparison
Compare vendors
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Core Peptides5.5/10 | $138.00 | $27.60 | Apr 16, 2026 | Buy → |
| BioLongevity Labs4/10 | $279.97 | $28.00 | Apr 16, 2026 | Buy → |
Research details
PNC-27 — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Overview
About PNC-27
Mechanism of action
Synthetic peptide containing p53 activation domain fused to penetratin cell-penetrating sequence; selectively inserts into membranes of cancer cells (which overexpress HDM2); induces apoptosis in cancer cells while leaving normal cells unharmed.
Safety profile
Limited human data. Animal studies show selective cancer cell killing with minimal normal cell toxicity. Long-term safety profile not established. · ⚠️ FDA has explicitly warned against PNC-27 products; documented bacterial contamination (Variovorax paradoxus) in marketed material; ZERO verified human trials; marketed with unsubstantiated cancer-cure claims. Experimental only — never a usable cancer therapy.
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops PNC-27 below your target.
Related pages
More on PNC-27
Research
Studies & key findings
- ⚠️ PNC-27 is an unapproved experimental anticancer peptide that the FDA has explicitly warned against, with documented bacterial contamination in marketed products and NO verified human clinical trial data.
- It is a 32-amino-acid chimeric peptide (a p53/HDM-2-binding domain fused to a membrane-penetrating sequence) studied in cell lines for selectively lysing cancer cells via membrane HDM-2.